肺癌蛋白质组学研究进展的启示

Research Progress on Proteomics in Lung Cancer

肺癌是全球发病率和死亡率最高的恶性肿瘤之一,随着蛋白质组学的发展,其方法应用于肺癌的相关研究,有助于揭示肺癌的发病机制、寻找早期诊断标志物、预测转移与预后及选择治疗方案。科学的内部矛盾以及科技进步推动着肺癌蛋白质组学的不断发展,其发展是一个从还原论到系统论,最终实现还原论与系统论辩证统一的过程。

Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. With the development of proteomics, its methods are applied to revealing the pathogenesis of lung cancer, searching the markers of diagnosis, predicting the metastasis and prognosis and selecting the therapies. The inner contradiction of science and technology advancement are promoting the development of proteomics of lung cancer, and the development reflects a process from the reductionism to the system theory, then to the unity of the two theories.